Pfizer Television - Search News

Pfizer COVID-19 Vaccine Sales Tumble

Pfizer raises earnings outlook as COVID vaccine sales drive Q3 beat

Pfizer (PFE) exceeded Street forecasts with its Q3 2025 results on Tuesday, thanks mainly to sales from its COVID vaccine developed with BioNTech (BNTX), and the company raised its full-year earnings outlook while reaffirming the revenue guidance.

· 1d · on MSN

Pfizer’s revenue falls as COVID sales and vaccine recommendations continue to fade

· 19h · on MSN

Pfizer COVID-19 vaccine sales tumble after government guidance on the shots narrows

Novo Nordisk, Pfizer sweeten bid for Metsera

Digest more

· 1d · on MSN

Novo Nordisk hikes Metsera bid to up to $10B in competition with rival Pfizer

Novo Nordisk is raising the stakes in its push to outbid rival Pfizer for the development-stage drugmaker Metsera.

· 9h · on MSN

Novo Nordisk CEO: Confident we will close Metsera deal

KTBS 3 · 6d

Novo Nordisk launches bidding war with Pfizer for obesity drugmaker Metsera

WGN-TV

Pfizer amps up push into obesity treatments with $4.9B deal for Metsera

Five months after ending development of its own obesity treatment, Pfizer is accelerating its push into the rapidly growing field with a nearly $5 billion acquisition. The COVID-19 vaccine and ...

Is It Time to Dump Your Shares of Pfizer?

Pfizer also has set its sights on becoming a giant in oncology, and to support this, completed the acquisition of Seagen in 2023. Two of Seagen's products in the most recent quarter delivered ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results